Science Explorer Back to mapMap
Discussion
Company · Limoges · France

Oncomedics (France)

oncomedics.comROR OpenAlex
Research works
16
▲ 394% vs 2018-21
Citations
98
6.2 per fractional work
Top-10% rate
8.9%
all institutions 10.0%
Open access
20%
world 40%
International
8%
world 18%
Oncomedics (France)

Not ranked overall: Oncomedics (France) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Oncomedics (France) work in?

In all years, 44% of research at Oncomedics (France) is in Health Sciences, 29% in Life Sciences. Its largest fields are Medicine (44%), Biochemistry, Genetics and Molecular Biology (26%), Engineering (21%). It does 1.5× the world's share of Health Sciences.

Health Sciences: 7 fractional works · 44.0% of its workMedicine: 7 fractional works · 44.0% of its workOncology: 3 fractional works · 21.4% of its workPulmonary and Respiratory Medicine: 2 fractional works · 10.3% of its workPsychiatry and Mental health: 1 fractional works · 4.2% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 2.1% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 1.6% of its workPathology and Forensic Medicine: 0 fractional works · 1.2% of its workInfectious Diseases: 0 fractional works · 1.1% of its workSurgery: 0 fractional works · 0.9% of its workHepatology: 0 fractional works · 0.6% of its workBiochemistry: 0 fractional works · 0.3% of its workHematology: 0 fractional works · 0.3% of its workLife Sciences: 5 fractional works · 29.3% of its workBiochemistry, Genetics and Molecular Biology: 4 fractional works · 26.1% of its workBiotechnology: 2 fractional works · 11.5% of its workCancer Research: 1 fractional works · 5.6% of its workMolecular Biology: 1 fractional works · 4.6% of its workCell Biology: 0 fractional works · 2.1% of its workGenetics: 0 fractional works · 2.1% of its workImmunology and Microbiology: 0 fractional works · 2.5% of its workImmunology: 0 fractional works · 2.5% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.7% of its workPharmaceutical Science: 0 fractional works · 0.7% of its workPhysical Sciences: 4 fractional works · 26.6% of its workEngineering: 3 fractional works · 21.2% of its workBiomedical Engineering: 3 fractional works · 18.3% of its workElectrical and Electronic Engineering: 0 fractional works · 1.8% of its workComputational Mechanics: 0 fractional works · 1.1% of its workChemistry: 0 fractional works · 2.2% of its workPhysical and Theoretical Chemistry: 0 fractional works · 1.1% of its workOrganic Chemistry: 0 fractional works · 1.1% of its workComputer Science: 0 fractional works · 1.6% of its workComputational Theory and Mathematics: 0 fractional works · 1.6% of its workMathematics: 0 fractional works · 0.8% of its workModeling and Simulation: 0 fractional works · 0.5% of its workStatistics and Probability: 0 fractional works · 0.3% of its workPhysics and Astronomy: 0 fractional works · 0.5% of its workRadiation: 0 fractional works · 0.5% of its workMaterials Science: 0 fractional works · 0.3% of its workMaterials Chemistry: 0 fractional works · 0.3% of its workALL ITS WORKOncomedics(France)16fractional works, all years
Life Sciences29%Physical Sciences27%Health Sciences44%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 3 domains and 10 fields, with their numbers
    1. Medicine744.0%
    1. Biochemistry, Genetics and Molecular Biology426.1%
    2. Immunology and Microbiology02.5%
    3. Pharmacology, Toxicology and Pharmaceutics00.7%
    1. Engineering321.2%
    2. Chemistry02.2%
    3. Computer Science01.6%
    4. Mathematics00.8%
    5. Physics and Astronomy00.5%
    6. Materials Science00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 5.47× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 3.82× its world share, 0 worksImmunology and Micro…Chemistry: 1.14× its world share, 0 worksChemistryComputer Science: 0.23× its world share, 0 worksComputer ScienceEngineering: 1.32× its world share, 2 worksEngineeringMedicine: 2.27× its world share, 4 worksMedicine1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 5.5×. Every wedge is a field page.

All 6 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology5.47×3 works
  2. Immunology and Microbiology3.82×0 works
  3. Medicine2.27×4 works
  4. Engineering1.32×2 works
  5. Chemistry1.14×0 works
  6. Computer Science0.23×0 works

Who are the top researchers at Oncomedics (France)?

Ranked on the quality score, Damien France lead among researchers whose main affiliation is Oncomedics (France).

  1. 1 Damien France France · #2,925,058 worldwide 6 citations · 16 works
All ranked researchers at Oncomedics (France)

What are the most cited papers from Oncomedics (France)?

The most cited paper from Oncomedics (France) is "Periostin‐ and podoplanin‐positive cancer‐associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma" (Cindy Neuzillet, Rémy Nicolle, Jérôme Raffenne et al., 2022), with 68 citations. Next come "Discrimination of colorectal cancer cell lines using microwave biosensors" (67) and "Microfluidic biosensors for microwave dielectric spectroscopy" (59).

Most cited papers
#PaperReleasedCitations
1 Periostin‐ and podoplanin‐positive cancer‐associated fibroblast subtypes cooperate to shape the inflamed tumor microenvironment in aggressive pancreatic adenocarcinoma Cindy Neuzillet, Rémy Nicolle, Jérôme Raffenne et al. · The Journal of Pathology Open access 14 Sep 2022 68
2 Discrimination of colorectal cancer cell lines using microwave biosensors L.Y. Zhang, Christophe Bounaix Morand Du Puch, C. Dalmay et al. · Sensors and Actuators A Physical 4 Apr 2014 67
3 Microfluidic biosensors for microwave dielectric spectroscopy Jonathan Leroy, C. Dalmay, Alaeddine Landoulsi et al. · Sensors and Actuators A Physical 11 Apr 2015 59
4 Microbiome and pancreatic ductal adenocarcinoma Annemilaï Tijeras‐Raballand, Marc Hilmi, Lucile Astorgues‐Xerri et al. · Clinics and Research in Hepatology and Gastroenterology 17 Feb 2021 29
5 Biomarkers in Hepatobiliary Cancers: What Is Useful in Clinical Practice? Alice Boilève, Marc Hilmi, Matthieu Delaye et al. · Cancers Open access 30 May 2021 26
All 27 most cited papers, with filters and sorting

Which research topics does Oncomedics (France) publish most on?

By volume in 2022-now: Nanoplatforms for cancer theranostics, Cancer Research and Treatments, Cancer Cells and Metastasis and Cancer, Stress, Anesthesia, and Immune Response.

Nanoplatforms for cancer…2Nanoplatforms for cancer theranostics: 2 fractional worksCancer Research and Treatments: 1 fractional worksCancer Cells and Metastasis: 1 fractional worksCancer, Stress, Anesthesia, and Immune Response: 1 fractional worksHER2/EGFR in Cancer Research: 0 fractional worksBrain Metastases and Tre…0Brain Metastases and Treatment: 0 fractional worksInhalation and Respiratory Drug Delivery: 0 fractional worksAdvanced Breast Cancer Therapies: 0 fractional worksinterferon and immune responses: 0 fractional worksZebrafish Biomedical Research Applications: 0 fractional works
Biomedical EngineeringBiotechnologyOncologyPsychiatry and Mental health3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Nanoplatforms for cancer theranostics Biomedical Engineering 2 works
  2. 2 Cancer Research and Treatments Biotechnology 1 works
  3. 3 Cancer Cells and Metastasis Oncology 1 works
  4. 4 Cancer, Stress, Anesthesia, and Immune Response Psychiatry and Mental health 1 works
  5. 5 HER2/EGFR in Cancer Research Oncology 0 works
  6. 6 Brain Metastases and Treatment Pulmonary and Respiratory Medicine 0 works
  7. 7 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 0 works
  8. 8 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
  9. 9 interferon and immune responses Immunology 0 works
  10. 10 Zebrafish Biomedical Research Applications Cell Biology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available19.9%not open80.1%

World: 40% of research is openly available.

with international co-authors7.7%domestic only92.3%

World: 18% is written across borders.

How has Oncomedics (France)'s research output changed?

Output in 2022-2025 was 394% higher than in 2018-2021.

still counting2010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Oncomedics (France) as a percentage of every work published that year, 0.000021% in 2023.

still counting0.000025%0.000050%0.000075%Oncomedics (France)0.000070% in 202520102020

Fractional works of Oncomedics (France) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Limoges

All research institutions in Limoges

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Oncomedics (France). Posts are plain text and can be reported.